Coagulation tests

Ended Purchase Order Awarded Last action

Contract number
W9114F22P0002
Awardee
Awarding agency
Obligated
$278,613

Award facts

Contract value 79% obligated
  • $278,613.03 Current, with exercised options
  • $350,670.94 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00005 · Provide the landstuhl regional medical center, germany with coagulation test materials to rule out deep vein thrombosis (DVT) and pulmonary embolism (PE) in… $67,804
Other Administrative Action P00004 $0
Funding Only Action P00003 $64,005
Exercise an Option P00002 · Providing the landstuhl regional medical center, germany with coagulation testing materials to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) of… $0
Exercise an Option P00001 $74,746
Original award $72,058

About this award

The Defense Health Agency awarded a $350,670.94 firm-fixed-price purchase order to Werfen GMBH for coagulation testing materials and services at Landstuhl Regional Medical Center in Germany. The contract, awarded December 1, 2021, extends through November 30, 2026, and supports diagnostic testing to rule out deep vein thrombosis and pulmonary embolism in patient populations. The solicitation, posted in August 2021, sought vendors capable of providing equipment, supplies, maintenance, repair services, and reagents for approximately 6,550 annual tests encompassing prothrombin time, activated partial thromboplastin time, fibrinogen, and D-dimer testing. The contract structure includes a base period from December 1, 2021 through November 30, 2022, with four one-year option periods.

No set-aside designation was used in this award. Evaluation was conducted using lowest-price technically acceptable criteria, requiring vendors to demonstrate technical capability for installation, validation, training, and ongoing maintenance support. As a purchase order, this contract provides direct procurement authority for the medical center's coagulation testing requirements, supporting the Defense Health Agency's mission to deliver healthcare services to the military community stationed in Germany. The firm-fixed-price structure establishes predictable costs for the government while incentivizing contractor efficiency in delivering the specified diagnostic materials and services.

Quick answers

Who was awarded contract W9114F22P0002?

W9114F22P0002 was awarded to Werfen GMBH by Medical Command (Department of the Army) on December 1, 2021.

How much is contract W9114F22P0002 worth?

The government has obligated $278,613 on W9114F22P0002. Its potential value, with all options, is $350,671.

Which agency awarded contract W9114F22P0002?

Medical Command (Department of the Army) awarded W9114F22P0002, with funding from Defense Health Agency (Department of Defense).

Was contract W9114F22P0002 competed?

The extent of competition for W9114F22P0002 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award